↓ Skip to main content

Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy

Overview of attention for article published in Journal for Immunotherapy of Cancer, September 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
5 X users

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
28 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy
Published in
Journal for Immunotherapy of Cancer, September 2019
DOI 10.1186/s40425-019-0725-7
Pubmed ID
Authors

Jing Shi, Chen Chen, Rui Ju, Qingzhu Wang, Juan Li, Lei Guo, Caiying Ye, Dechang Zhang

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 28 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 18%
Student > Master 5 18%
Researcher 4 14%
Student > Bachelor 3 11%
Student > Doctoral Student 1 4%
Other 1 4%
Unknown 9 32%
Readers by discipline Count As %
Medicine and Dentistry 6 21%
Pharmacology, Toxicology and Pharmaceutical Science 5 18%
Biochemistry, Genetics and Molecular Biology 4 14%
Immunology and Microbiology 1 4%
Agricultural and Biological Sciences 1 4%
Other 2 7%
Unknown 9 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 August 2020.
All research outputs
#16,010,525
of 25,774,185 outputs
Outputs from Journal for Immunotherapy of Cancer
#2,660
of 3,513 outputs
Outputs of similar age
#195,275
of 352,645 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#70
of 79 outputs
Altmetric has tracked 25,774,185 research outputs across all sources so far. This one is in the 36th percentile – i.e., 36% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,513 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.5. This one is in the 22nd percentile – i.e., 22% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 352,645 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 79 others from the same source and published within six weeks on either side of this one. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.